FDA Regulation On Gene Therapy | The Brainstorm EP 96

FDA Regulation On Gene Therapy | The Brainstorm EP 96

In this episode of the Brainstorm, Sam, Nick, and Multiomics Research Analyst, Shea Wihlborg, dive into the complexities of the FDA's recent decisions and their implications for gene therapy. They discuss the controversial halt of a Duchenne muscular dystrophy treatment, the role of AI in drug discovery, and the exciting future of genomics.

If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.

Key Points From This Episode:

  • Discussion on the FDA's recent halt of a Duchenne muscular dystrophy treatment due to safety concerns.
  • Exploration of the role of AI in improving drug discovery and clinical trials.
  • Insights into the future of gene therapies for both rare and common diseases.
  • The potential impact of regulatory changes on innovation in the biotech industry.

For more updates on Public.com:

Website: https://public.com/

YouTube: @publicinvest

X: https://twitter.com/public

Episoder(299)

Enabling the Metaverse Revolution with Improbable CEO Herman Narula

Enabling the Metaverse Revolution with Improbable CEO Herman Narula

As improbable as it may seem, the metaverse is well under construction, but not in the way it’s been communicated to us in the mainstream. Joining us today to reconstruct all we know about the metaver...

4 Aug 202255min

E-Commerce in Indonesia with Bukalapak President Teddy Oetomo

E-Commerce in Indonesia with Bukalapak President Teddy Oetomo

E-commerce is taking the world by storm and today, we are joined by the President of Bukalapak, Teddy Oetomo, to find out how they’re revolutionizing the market in Indonesia. Bukalapak is a publicly t...

28 Jul 202237min

Discussing Our Roku Valuation with Nick Grous and Andrew Kim

Discussing Our Roku Valuation with Nick Grous and Andrew Kim

Please note: as of 3/31/22, ARK’s clients own greater than 1% of the shares outstanding of Roku Inc. We believe there’s a major shift taking place in the TV ecosystem in terms of people moving from li...

21 Jul 202229min

Exploring Space Laser Communication with Mynaric CEO Bulent Altan

Exploring Space Laser Communication with Mynaric CEO Bulent Altan

Please note: as of 3/31/22, ARK’s clients own greater than 1% of the shares outstanding of Mynaric. Mynaric CEO Bulent Atlan began his career as one of the first employees at the then newly-establishe...

13 Jul 202249min

Finding Growth with Cathie Wood

Finding Growth with Cathie Wood

On this episode of FYI, we showcase our latest episode of In The Know, a monthly video series on which our CEO and CIO Cathie Wood discusses fiscal policy, monetary policy, market signals, economic in...

7 Jul 202244min

Discussing our Zoom Valuation with Will Summerlin and Andrew Kim

Discussing our Zoom Valuation with Will Summerlin and Andrew Kim

Please note: as of 3/31/22, ARK’s clients own greater than 1% of the shares outstanding of Zoom Video Communications. Read our full valuation article here. According to ARK’s open-source research and ...

30 Jun 202235min

The Future of Blockchain and Healthcare with Dr. Alex Cahana

The Future of Blockchain and Healthcare with Dr. Alex Cahana

Today’s guest believes strongly that healthcare needs blockchain and blockchain needs healthcare. In this episode, Dr. Alex Cahana returns to the show to discuss how blockchain can be the impetus for ...

23 Jun 20221h 1min

End to End 3D Printing with Velo3D CEO Benny Buller

End to End 3D Printing with Velo3D CEO Benny Buller

Please note: as of 3/31/22, ARK’s clients own greater than 1% of the shares outstanding of Velo3D. ARK expects 3D printing to revolutionize manufacturing by collapsing the time between design and prod...

15 Jun 202253min

Populært innen Business og økonomi

lydartikler-fra-aftenposten
stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
livet-pa-veien-med-jan-erik-larssen
pengepodden-2
finansredaksjonen
pengesnakk
tid-er-penger-en-podcast-med-peter-warren
stormkast-med-valebrokk-stordalen
utbytte
morgenkaffen-med-finansavisen
liberal-halvtime
okonomiamatorene
rss-politisk-preik
rss-markedspuls-2
lederpodden
rss-sunn-okonomi